Related Experiment Video
Updated: Nov 2, 2025

11:32
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
15.2K
Hypersensitivity Pneumonitis in a Pediatric Patient
Madiha Naz1, Shazia Parveen1, Afsheen Asghar Khan1
1Department of Pediatric Medicine, Nishtar Medical University, Multan, Pakistan.
Summary
Hypersensitivity pneumonitis (HP) is a rare lung disease caused by inhaling antigens. This case report details a child
Area of Science:
- Pulmonology
- Pediatric Allergy
- Immunology
Background:
- Hypersensitivity pneumonitis (HP) is an interstitial lung disease triggered by inhaled antigens.
- Diagnosis relies on exposure history, clinical signs, and imaging.
- Management involves antigen avoidance and corticosteroids.
Observation:
- A 7.5-year-old girl presented with cough and severe respiratory distress.
- The patient was diagnosed with hypersensitivity pneumonitis.
Findings:
- This case highlights a pediatric presentation of HP.
- Illustrates the diagnostic challenges and clinical course in children.
Implications:
- Emphasizes the importance of considering HP in pediatric respiratory illness.
- Underscores the need for thorough antigen exposure assessment in children.
- Informs clinical practice regarding diagnosis and management of pediatric HP.
Related Concept Videos
Pneumonia I: Introduction
450
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
450
Pharmacokinetics in Pediatric Patients: Drug Excretion
55
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
55
Hypersensitivities
3.2K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
3.2K
Pharmacokinetics in Pediatric Patients: Drug Metabolism
48
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
48
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
49
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
49
Pneumonia II: Pathophysiology
1.4K
The pathophysiology of pneumonia involves the following steps:
1.4K

